{"version":"1.0","type":"link","title":"Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.","author_name":"Song H 외","author_url":"https://prs-insight.online/author/Song%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/148470","thumbnail_width":1200,"thumbnail_height":630}